MWNA
CGEN icon

Marshall Wace North America’s Compugen CGEN Stock Holding History

Marshall Wace North America’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,331
Closed -$135K – 1459
2021
Q2 		$135K Buy
+16,331
New +$133K ﹤0.01% 1376
2020
Q2 		– Sell
-17,120
Closed -$124K – 1194
2020
Q1 		$124K Buy
+17,120
New +$134K ﹤0.01% 964
2018
Q3 		– Sell
-34,577
Closed -$114K – 970
2018
Q2 		$114K Buy
+34,577
New +$130K ﹤0.01% 1310

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace North America's CGEN Position: Q3 2021 in Review

Marshall Wace North America sold out of Compugen (CGEN) in Q3 2021, closing a stake of 16,331 shares — an estimated $135K sold.

Marshall Wace North America first reported a position in CGEN in Q2 2018 and held it in 3 quarters. The position peaked at $135K in Q2 2021. 108 funds tracked by Wall St. Rank hold CGEN as of Q3 2021.

  • Marshall Wace North America reported no remaining Compugen position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 16,331 Compugen shares in Q3 2021, an estimated $135K.
  • Marshall Wace North America first reported a position in Compugen in Q2 2018 and held it in 3 quarters.
  • Marshall Wace North America's Compugen position peaked at $135K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Compugen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.